Vimarsana
Biggest News Aggregation in the World

Page 4 - Licence Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Licence Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Licence Application Today - Breaking & Trending Today

BBCNEWS HARDtalk August 4, 2021 23:38:00 - Vimarsana News

BBCNEWS HARDtalk August 4, 2021 23:38:00

Do you think you made a mistake, for example, in not including enough elderly people in your initial trial? because that caused some concern about whether your particular vaccine was, in the early days of this crisis, good at ensuring protection for older people, because you hadn't used many in your trials. in fact, we have the same proportion of older adults in our trials as all the other developers. but the specific issue here was at the time when we had our provisional application, we didn't have enough cases of disease in older adults. and the reason for that is just that, as we developed ...

MMO gives consent to ABP's £25 million development of Lowestoft Eastern Energy Facility for offshore wind - Vimarsana News

MMO gives consent to ABP's £25 million development of Lowestoft Eastern Energy Facility for offshore wind

MMO grants marine licence to marine development project following collaboration and joint working.

Source: gov.uk
Unigold Updates 2022 Programs for Neita Concession - Vimarsana News

Unigold Updates 2022 Programs for Neita Concession

Application for Exploitation License expected in Q1/2022Initiation of feasibility work underwayInitiation of Environmental and Social Impact Assessment is...

BBCNEWS HARDtalk August 8, 2021 12:40:00 - Vimarsana News

BBCNEWS HARDtalk August 8, 2021 12:40:00

That, as we developed the vaccine, the safety monitoring board's view was that we should recruit the older adults a little bit later in the trial. so by the time of that first licence application, they hadn't all had enough time to get the efficacy results around severe disease. so that's one reason. and of course, the other is that, particularly here in the uk, but certainly also in our large study in brazil, older adults are rather more cautious during the pandemic. and so they have had less exposure to the virus. so it took a bit longer to be able to generate the data. so it's not that ther...

BBCNEWS HARDtalk August 6, 2021 03:39:00 - Vimarsana News

BBCNEWS HARDtalk August 6, 2021 03:39:00

Here was at the time when we had our provisional application, we didn't have enough cases of disease in older adults. and the reason for that is just that, as we developed the vaccine, the safety monitoring board's view was that we should recruit the older adults a little bit later in the trial. so by the time of that first licence application, they hadn't all had enough time to get the efficacy results around severe disease. so that's one reason. and of course, the other is that, particularly here in the uk, but certainly also in our large study in brazil, older adults are rather more cautiou...